The insulin-like growth factor system in the circulation of patients with viral infections

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 10, 2004, Pages 1127-1131

  Baričević, Ivona ^a   Nedić, Olgica ^a   Nikolić, Judith Anna ^a   Nedeljković, Jasminka ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Torlak Institute   (Serbia)

Author keywords

Adenovirus; Cortisol; Cytomegalovirus; Herpes simplex virus; Insulin like growth factor; Insulin like growth factor binding protein; Rotavirus

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADENOVIRUS; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HERPES SIMPLEX; HORMONE INHIBITION; HUMAN; HUMORAL IMMUNITY; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RNA VIRUS INFECTION; ROTAVIRUS;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; ROTAVIRUS; SIMPLEXVIRUS;

EID: 8344227651     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.231     Document Type: Article

References (35)

1. Von Horn H, Ekstrom C, Ellis E, Olivecrona H, Einarsson C, Tally M. GH is a regulator of IGF2 promoter-specific transcription in human liver. J Endocrinol 2002;172:457-65.
2. Le Roith D. The insulin-like growth factor system. Exp Diab Res 2003;4:205-12.
3. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999;96:7324-9.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
5. Yu H, Mistry J, Nicar MJ, Khosravi J, Diamandis A, Doom J. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6 and ALS) in blood circulation. J Clin Lab Anal 1999;13:166-72.
6. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-54.
7. Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin N Am 2003;32:385-410.
8. Baxter RC. Changes in the IGF-IGFBP axis in critical illness. Best Pract Res Clin Endocrinol Metab 2001;15:421-34.
9. Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 2001;15:495-511.
10. Goodgame RW. Viral infections of the gastrointestinal tract. Gastrointest Infect 1999;1:292-300.
11. Taylor TJ, Brockman MA, McNamee EE, Knipe DM. Herpes simplex virus. Front Biosci 2002;7:D752-64.
12. Bobak DA. Gastrointestinal infections caused by cytomegalovirus. Curr Infect Dis Rep 2003;5:101-7.
13. Pass RF. Cytomegalovirus infection. Pediatr Rev 2002;23:163-9.
14. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 2001;3:1145-56.
15. Ryan MJ, Wall PG, Adak GK, Evans HS, Cowden JM. Outbreaks of infectious intestinal disease in residential institutions in England and Wales. J Infect 1994;34:49-54.
16. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect 2003;9:247-62.
17. Lenette EH, Schmidt NJ, editors. Diagnostic procedures for viral and rickettsial infections, 4th ed. Washington: PHA, 1969.
18. Nikolić JA, Ratković M, Nedić O. Determination of insulin-like growth factor-I by radioimmunoassay. J Serb Chem Soc 1996;61:1149-57.
19. Nikolić JA, Nedić O, Masnikosa R. Determination of insulin-like growth factor-II in human serum. J Serb Chem Soc 1998;63:805-15.
20. Nikolić JA, Nedić O, Masnikosa R. Peripheral serum concentrations of insulin-like growth factors (IGF-I and IGF-II) decrease with age in healthy adults. Genetika 2000;32:155-65.
21. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Chem 1986;154:138-43.
22. Nedić O, Nikolić JA, Hajduković-Dragojlović Lj, Todorović V, Masnikosa R. Alterations of IGF-binding proteins in patients with alcoholic liver cirrhosis. Alcohol 2000;21:223-9.
23. Nedić O, Nikolić JA, Prišić S, Aćimović J, Hajduković-Dragojlović LJ. Reactivity of IGF binding protein-3 isoforms towards concanavalin A in healthy adults and subjects with cirrhosis. Addict Biol 2003;8:81-8.
24. Masnikosa R, Nikolić JA, Nedić O. Membrane-associated insulin-like growth factor (IGF) binding structures in placental cells. J Serb Chem Soc 2003;68:811-8.
25. Heemskerk VH, Daemen MARC, Buurman WA. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cyt Growth Factor Rev 1999;10:5-14.
26. McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis 1991;11:265-77.
27. Helle SI, Ueland T, Ekse D, Froland SS, Holly JM, Lonning PE, et al. The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy. J Clin Endocrinol Metab 2001;86: 227-33.
28. Lang CH, Nystrom GJ, Frost RA. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha. Growth Horm IGF Res 2001;11:250-60.
29. Johann-Liang R, O'Neill L, Cervia J, Haller I, Giunta Y, Licholai T, et al. Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus. AIDS 2000;14:683-90.
30. Su Q, Liu YF, Zhang JF, Yhang SX, Li DF, Yang JJ. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994;20:788-99.
31. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. J Cell Physiol 1993;154:486-95.
32. Zijlstra RT, Donovan SM, Odle J, Gelberg HB, Petschow BW, Gaskins HR. Protein-energy malnutrition delays small-intestinal recovery in neonatal pigs infected with rotavirus. J Nutr 1997;127:1118-27.
33. Srivastava R, Curtis M, Hendrickson S, Burns WH, Hosenpud JD. Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy. Transplantation 1999;68:1568-73.
34. Hammond GL. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab 1995; 6:298-304.
35. Beishuizen A, Vermes I, Haanen C. Endogenous mediators in sepsis and septic shock. Adv Clin Chem 1999;33:55-131.